Dipeptide Alanyl Glutamine and Postoperative Insulin Resistance in Colon Carcinoma Patients

NCT00922688 · clinicaltrials.gov ↗

NA

Phase

UNKNOWN

Status

30

Enrollment

OTHER

Sponsor class

Conditions

Colon Carcinoma

Interventions

DRUG: Dipeptide Alanyl-Glutamine
DRUG: Placebo
DRUG: Dipeptide Alanyl-Glutamine

Sponsor

Medical Center Alkmaar